title: Antiretroviral drugs in Africa: a public health versus a market approach.
authors.forename: Bernard
authors.initials: B
authors.lastname: Taverne
authors.forename: Alice
authors.initials: A
authors.lastname: Desclaux
authors.forename: Mame B
authors.initials: MB
authors.lastname: Koita Fall
authors.forename: Eric
authors.initials: E
authors.lastname: Delaporte
authors.forename: Ibra
authors.initials: I
authors.lastname: Ndoye
mesh_terms: D000349:Africa; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004349:Drug Packaging / Q000592:standards*; D015658:HIV Infections / Q000188:drug therapy*; D006295:Health Resources; D006297:Health Services Accessibility; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D019829:Nevirapine / Q000627:therapeutic use; D011634:Public Health; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D019259:Lamivudine; D015215:Zidovudine; D019829:Nevirapine